MedPath

Comparsion of amitriptyline and capsaicn in painful diabetic neuropathy

Phase 2
Conditions
Painfull Diabetic Polyneuropathy.
Diabetic polyneuropathy
Registration Number
IRCT201209238308N2
Lead Sponsor
Vice-chancellor of Research and Technology,Hamedan university of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
100
Inclusion Criteria

Type two diabetic patients with Painfull diabetic neuropathy Exclusion criteria: Duration of diabetes less than one year; Age <30 or >70 years; VAS<4; Type one diabetes; Other causes of neuropathy other than diabetes; Opiom or alcohol users; Use of other drugs for pain reduction; Hepatic or renal failure; HA1C=9; Pregnancy or lactation; Ulcer or infection of foot; Hypersensitivity to pepper

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Pain intensity. Timepoint: At baseline, one, two and three month later. Method of measurement: Visual Analouge Scale.
Secondary Outcome Measures
NameTimeMethod
Any adverse effect. Timepoint: one, two and three month later. Method of measurement: Questioner.
© Copyright 2025. All Rights Reserved by MedPath